ATE286980T1 - Die p110-delta katalytische untereinheit der phosphatidylinositol-3-kinase - Google Patents

Die p110-delta katalytische untereinheit der phosphatidylinositol-3-kinase

Info

Publication number
ATE286980T1
ATE286980T1 AT97948540T AT97948540T ATE286980T1 AT E286980 T1 ATE286980 T1 AT E286980T1 AT 97948540 T AT97948540 T AT 97948540T AT 97948540 T AT97948540 T AT 97948540T AT E286980 T1 ATE286980 T1 AT E286980T1
Authority
AT
Austria
Prior art keywords
delta
catalytic subunit
phosphatidylinositol
kinase
delta catalytic
Prior art date
Application number
AT97948540T
Other languages
English (en)
Inventor
David H Chantry
Merl F Hoekstra
Douglas A Holtzman
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Application granted granted Critical
Publication of ATE286980T1 publication Critical patent/ATE286980T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indexing, Searching, Synchronizing, And The Amount Of Synchronization Travel Of Record Carriers (AREA)
  • Magnetic Record Carriers (AREA)
AT97948540T 1996-11-25 1997-11-25 Die p110-delta katalytische untereinheit der phosphatidylinositol-3-kinase ATE286980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/777,405 US5858753A (en) 1996-11-25 1996-11-25 Lipid kinase
PCT/US1997/021655 WO1998023760A1 (en) 1996-11-25 1997-11-25 Phosphatidylinositol 3-kinase p110 delta catalytic subunit

Publications (1)

Publication Number Publication Date
ATE286980T1 true ATE286980T1 (de) 2005-01-15

Family

ID=25110168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97948540T ATE286980T1 (de) 1996-11-25 1997-11-25 Die p110-delta katalytische untereinheit der phosphatidylinositol-3-kinase

Country Status (11)

Country Link
US (3) US5858753A (de)
EP (2) EP1522584A3 (de)
JP (1) JP2000505653A (de)
AT (1) ATE286980T1 (de)
AU (1) AU5458798A (de)
CA (1) CA2243944A1 (de)
DE (1) DE69732228T2 (de)
DK (1) DK0891428T3 (de)
ES (1) ES2236834T3 (de)
PT (1) PT891428E (de)
WO (1) WO1998023760A1 (de)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9611460D0 (en) * 1996-06-01 1996-08-07 Ludwig Inst Cancer Res Novel lipid kinase
US6046049A (en) * 1999-07-19 2000-04-04 Isis Pharmaceuticals Inc. Antisense modulation of PI3 kinase p110 delta expression
US6479716B2 (en) 2000-03-29 2002-11-12 Archer-Daniels-Midland Company Method of recovering 1,3-propanediol from fermentation broth
WO2001081346A2 (en) * 2000-04-25 2001-11-01 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
EP1939203B1 (de) 2000-04-25 2014-11-19 ICOS Corporation Hemmer der delta-Isoform der menschlichen Phosphatidyl-Inositol-3-Kinase
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
AU2001257571A1 (en) * 2000-05-10 2001-11-20 Icos Corporation Phosphatidyl inositol 3-kinase delta binding partner
US6330941B1 (en) * 2000-05-25 2001-12-18 Habasit Ag Radius conveyor belt
US7829084B2 (en) * 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US7091004B1 (en) * 2001-06-08 2006-08-15 Immunex Corporation Regulation of translation for recombinant protein production
US7429596B2 (en) * 2003-06-20 2008-09-30 The Regents Of The University Of California 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
US20050054614A1 (en) * 2003-08-14 2005-03-10 Diacovo Thomas G. Methods of inhibiting leukocyte accumulation
WO2005016348A1 (en) * 2003-08-14 2005-02-24 Icos Corporation Method of inhibiting immune responses stimulated by an endogenous factor
WO2005067901A2 (en) * 2004-01-08 2005-07-28 Michigan State University Methods for treating and preventing hypertension and hypertension-related disorders
US7932260B2 (en) 2004-05-13 2011-04-26 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
WO2005112935A1 (en) * 2004-05-13 2005-12-01 Vanderbilt University Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
EP1755609A1 (de) * 2004-05-25 2007-02-28 Icos Corporation Verfahren zur behandlung und/oder prävention von überschiessender proliferation von hämatopoetischen zellen
JP2008520744A (ja) * 2004-11-19 2008-06-19 ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 抗炎症性ピラゾロピリミジン
CA2598409A1 (en) * 2005-02-17 2006-08-24 Icos Corporation Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
WO2006128679A2 (en) * 2005-05-31 2006-12-07 Martin Andreas Thurnher Phosphatidylinositol composition and 3'-phosphorylated lysophosphatidylinositols in the treatment of cancer and autoimmune diseases
SI1912675T1 (sl) 2005-07-25 2014-07-31 Emergent Product Development Seattle, Llc zmanjšanje števila celic B z uporabo molekul, ki se specifično vežejo na CD37 in CD20
NZ571182A (en) * 2006-04-04 2010-09-30 Univ California Pyrazolo[3,4-d]pyrimidines
AU2007323836B2 (en) * 2006-11-13 2013-04-18 Icos Corporation Thienopyrimidinones for treatment of inflammatory disorders and cancers
MX2009009968A (es) 2007-03-23 2009-10-08 Amgen Inc Compuestos heterociclicos y sus usos.
AU2008287195A1 (en) * 2007-07-06 2009-02-19 Emergent Product Development Seattle, Llc Binding peptides having a C-terminally disposed specific binding domain
US20110160232A1 (en) 2007-10-04 2011-06-30 Pingda Ren Certain chemical entities and therapeutic uses thereof
CA2716334A1 (en) * 2007-11-13 2009-05-22 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
NZ587051A (en) 2008-01-04 2012-12-21 Intellikine Llc Isoquinolinone derivatives, compositions and methods of inhibiting phosphatidyl inositol-3 kinase (pi3 kinase)
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
WO2009114874A2 (en) 2008-03-14 2009-09-17 Intellikine, Inc. Benzothiazole kinase inhibitors and methods of use
US8637542B2 (en) 2008-03-14 2014-01-28 Intellikine, Inc. Kinase inhibitors and methods of use
EP2132228B1 (de) * 2008-04-11 2011-06-22 Emergent Product Development Seattle, LLC Cd37-immuntherapeutikum und kombination mit bifunktionellem chemotherapeutikum davon
BRPI0915231A2 (pt) 2008-07-08 2018-06-12 Intellikine Inc compostos inibidores de quinase e métodos de uso
US20110224223A1 (en) * 2008-07-08 2011-09-15 The Regents Of The University Of California, A California Corporation MTOR Modulators and Uses Thereof
US8703778B2 (en) 2008-09-26 2014-04-22 Intellikine Llc Heterocyclic kinase inhibitors
ES2570429T3 (es) 2008-10-16 2016-05-18 Univ California Inhibidores de heteroaril quinasa de anillo condensado
US8476282B2 (en) * 2008-11-03 2013-07-02 Intellikine Llc Benzoxazole kinase inhibitors and methods of use
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
CA2975473C (en) 2008-11-13 2021-01-19 Gilead Calistoga Llc Therapies for hematologic malignancies
JP2012521994A (ja) 2009-03-24 2012-09-20 ギリアード カリストガ エルエルシー ２−プリニル−３−トリル−キナゾリノン誘導体のアトロプ異性体および使用方法
ES2548253T3 (es) * 2009-04-20 2015-10-15 Gilead Calistoga Llc Métodos para el tratamiento de tumores sólidos
CA2760791C (en) 2009-05-07 2017-06-20 Intellikine, Inc. Heterocyclic compounds and uses thereof
JP2012531435A (ja) 2009-06-25 2012-12-10 アムジエン・インコーポレーテツド ＰＩ３Ｋ阻害剤としての４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オン誘導体
EP2445902A2 (de) 2009-06-25 2012-05-02 Amgen, Inc Heterocyclische verbindungen und ihre verwendung als hemmer der pi3k-aktivität
BR112012000660A2 (pt) 2009-06-25 2016-11-16 Amgen Inc compostos heterociclos e seus usos
WO2010151740A2 (en) 2009-06-25 2010-12-29 Amgen Inc. Heterocyclic compounds and their uses
CA2768843A1 (en) 2009-07-21 2011-01-27 Gilead Calistoga Llc Treatment of liver disorders with pi3k inhibitors
WO2011047384A2 (en) 2009-10-16 2011-04-21 The Regents Of The University Of California Methods of inhibiting ire1
MX2012006953A (es) 2009-12-18 2012-10-09 Amgen Inc Compuestos heterociclicos y sus usos.
UY33304A (es) 2010-04-02 2011-10-31 Amgen Inc Compuestos heterocíclicos y sus usos
ES2593256T3 (es) 2010-05-21 2016-12-07 Infinity Pharmaceuticals, Inc. Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
WO2011159726A2 (en) 2010-06-14 2011-12-22 The Scripps Research Institute Reprogramming of cells to a new fate
AU2011272862A1 (en) 2010-06-30 2013-01-10 Amgen Inc. Heterocyclic compounds and their use as inhibitors of PI3K activity
AU2011271462A1 (en) 2010-06-30 2013-01-10 Amgen Inc. Nitrogen containing heterocyclic compounds as PIK3 -delta inhibitors
WO2012003278A1 (en) 2010-06-30 2012-01-05 Amgen Inc. Quinolines as p13k inhibitors
US8759371B2 (en) 2010-07-01 2014-06-24 Amgen Inc. Heterocyclic compounds and their uses
EP2588467A1 (de) 2010-07-01 2013-05-08 Amgen Inc. Heterocyclische verbindungen und ihre verwendung als hemmer der pi3k-aktivität
AU2011272850A1 (en) 2010-07-02 2013-01-10 Amgen Inc. Heterocyclic compounds and their use as inhibitors of PI3K activity
EP2635565A1 (de) 2010-11-04 2013-09-11 Amgen Inc. 5 -cyano-4, 6 -diaminopyrimidin oder 6 -aminopurinderivate als pi3k-delta-inhibitoren
WO2012064973A2 (en) 2010-11-10 2012-05-18 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX2013005567A (es) 2010-11-17 2013-10-30 Amgen Inc Derivados de quinolina como inhibidores de pik3.
EP2655342A1 (de) 2010-12-23 2013-10-30 Amgen Inc. Heterocyclische verbindungen und ihre verwendung
CN103648499B (zh) 2011-01-10 2017-02-15 无限药品股份有限公司 用于制备异喹啉酮的方法及异喹啉酮的固体形式
US9295673B2 (en) 2011-02-23 2016-03-29 Intellikine Llc Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
EP2734520B1 (de) 2011-07-19 2016-09-14 Infinity Pharmaceuticals, Inc. Heterocyclische verbindungen und ihre verwendung
CA2842190A1 (en) 2011-07-19 2013-01-24 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
WO2013032591A1 (en) 2011-08-29 2013-03-07 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
CA2846496C (en) 2011-09-02 2020-07-14 The Regents Of The University Of California Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
EP2790705B1 (de) 2011-12-15 2017-12-06 Novartis AG Verwendung von inhibitoren der aktivität oder funktion von pi3k
WO2013134288A1 (en) 2012-03-05 2013-09-12 Gilead Calistoga Llc Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
EA201491823A1 (ru) 2012-04-04 2015-01-30 Эмджен Инк. Гетероциклические соединения и их использование
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
JP2015532287A (ja) 2012-09-26 2015-11-09 ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア Ｉｒｅ１の調節
JP6207100B2 (ja) 2012-12-21 2017-10-04 ギリアード カリストガ エルエルシー イソキノリノンまたはキナゾリノンホスファチジルイノシトール３−キナーゼ阻害剤
CA2895782C (en) 2012-12-21 2017-08-22 Gilead Calistoga Llc Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
NZ714710A (en) 2013-06-14 2016-11-25 Gilead Sciences Inc Phosphatidylinositol 3-kinase inhibitors
CA2925944C (en) 2013-10-04 2023-01-10 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
JP2017502021A (ja) 2013-12-20 2017-01-19 ギリアード カリストガ エルエルシー ホスファチジルイノシトール３−キナーゼ阻害剤のためのプロセス方法
AU2014364414A1 (en) 2013-12-20 2016-06-30 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
EP4066834A1 (de) 2014-03-19 2022-10-05 Infinity Pharmaceuticals, Inc. Heterocyclische verbindungen zur verwendung in der behandlung von pi3k-gamma-vermittelten erkrankungen
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
EP3154960A1 (de) 2014-06-13 2017-04-19 Gilead Sciences, Inc. Phosphatidylinositol-3-kinase-hemmer
CN104155440B (zh) * 2014-07-16 2016-02-10 广东药学院 p110δ及其抗体在特异性标记滋养层巨细胞（pTGC）中的应用
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN108349985A (zh) 2015-09-14 2018-07-31 无限药品股份有限公司 异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2017223422A1 (en) 2016-06-24 2017-12-28 Infinity Pharmaceuticals, Inc. Combination therapies
CN114500360B (zh) * 2022-01-27 2022-11-11 河海大学 一种基于深度强化学习的网络流量调度方法以及系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169637A (en) * 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
US5180713A (en) * 1985-09-27 1993-01-19 Liposome Technology, Inc. Stabilized liposome/amphotercin B composition and method
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5185154A (en) * 1989-02-02 1993-02-09 Liposome Technology, Inc. Method for instant preparation of a drug containing large unilamellar vesicles
JP3533215B2 (ja) * 1990-07-31 2004-05-31 ザ リポソーム カンパニー，インコーポレイテッド アミノ酸及びペプチドのリポソーム内への蓄積
US5480906A (en) * 1994-07-01 1996-01-02 Eli Lilly And Company Stereochemical Wortmannin derivatives
US6043062A (en) * 1995-02-17 2000-03-28 The Regents Of The University Of California Constitutively active phosphatidylinositol 3-kinase and uses thereof
GB9611460D0 (en) * 1996-06-01 1996-08-07 Ludwig Inst Cancer Res Novel lipid kinase

Also Published As

Publication number Publication date
ES2236834T3 (es) 2005-07-16
EP0891428B1 (de) 2005-01-12
EP0891428A1 (de) 1999-01-20
US5858753A (en) 1999-01-12
US5882910A (en) 1999-03-16
DE69732228T2 (de) 2005-12-29
JP2000505653A (ja) 2000-05-16
AU5458798A (en) 1998-06-22
DE69732228D1 (de) 2005-02-17
PT891428E (pt) 2005-05-31
DK0891428T3 (da) 2005-05-30
CA2243944A1 (en) 1998-06-04
EP1522584A2 (de) 2005-04-13
EP1522584A3 (de) 2005-06-15
WO1998023760A1 (en) 1998-06-04
US5985589A (en) 1999-11-16

Similar Documents

Publication Publication Date Title
ATE286980T1 (de) Die p110-delta katalytische untereinheit der phosphatidylinositol-3-kinase
DE3876321T2 (de) Kopf zur messung des reflexionsvermoegens von entfernten proben.
NO892824L (no) Hoderem-anordning for gassmaske.
FI894627A0 (fi) Olefiinien polymeroinnissa käytettäviä katalysaattoreita
DE3866946D1 (de) Scheibe fuer scheibenbremse.
DE69022337D1 (de) 2-Stufenverfahren zur Synthese von Kohlenwasserstoffen.
DE58903886D1 (de) Bremsklotz, insbesondere fuer teilbelag-scheibenbremse.
DE3883743D1 (de) Aminosäuren, nützlich bei Leberstörungen.
DE68900526D1 (de) Bremsklotzzusammenbau.
FI904258A0 (fi) Mitomycin c stabila loesningar.
DE59006906D1 (de) Teilbelag-scheibenbremse.
IT1230333B (it) Procedimento per la fabbricazione di pezzi stampati ceramici.
DE69021758T2 (de) Photomagnetischer Komposit-Kopf.
NO895237L (no) Sementeringshode for oljebroenner.
DE68909016D1 (de) Zeolitische Zusammensetzung, anwendbar bei der Trennung von Olefinen.
DE3882806T2 (de) Bremsdruckregelgerät.
NO895017D0 (no) Understoettelse for katalysatorpakke.
DE69001579T2 (de) Schwimmsattel-scheibenbremse.
NO892123D0 (no) Fremgangsmaate for identifikasjon av skip.
DE58905275D1 (de) Verladebruecke.
ES1008845Y (es) Valvula compensadora para liquidos espumosos.
NO892244D0 (no) Fremgangsmaate til immundiagnostisk bestemmelse.
ES1004485Y (es) Base para suelos de vehiculos.
NO164861C (no) Skaaldesikring for blandeventil.
ATA325587A (de) Gasdruckregler, insbesondere fuer gasbrenner

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0891428

Country of ref document: EP

REN Ceased due to non-payment of the annual fee